Randomized trial · people

Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4

Checked against the paper Randomized trialPublished by PepVault

The takeaway

A daily 25 mg semaglutide pill led to clearly more weight loss than placebo over 64 weeks, with stomach and gut side effects in 74.0% of users.

Kind
Randomized trial
Studied in
People
Published
2025
Journal
N Engl J Med

What they tested

Does a once-daily 25 mg semaglutide pill lead to more weight loss than a placebo in adults with overweight or obesity who do not have diabetes?

How the study was done

A double-blind, randomized, placebo-controlled trial lasting 71 weeks at 22 sites in four countries. Adults without diabetes with a BMI (body-mass index) of 30 or higher, or 27 or higher plus at least one weight-related health problem, were assigned 2:1 to the pill (205 people) or a placebo, a dummy pill (102 people), with lifestyle support in both groups.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking semaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At week 64, body weight changed by an estimated -13.6% on oral semaglutide and -2.2% on placebo, a difference of -11.4 percentage points (95% confidence interval, -13.9 to -9.0). People on the pill were significantly more likely to lose at least 5%, 10%, 15% and 20% of their weight, and more often improved on a physical function score from a weight-related quality-of-life questionnaire (IWQOL-Lite-CT). Stomach and gut side effects were more common on the pill than on placebo (74.0% vs. 42.2%).

What it doesn’t show

The trial tested a single dose against placebo only, so it does not compare the pill with injectable semaglutide or other doses, and it excluded people with diabetes. It was funded by Novo Nordisk.

The paper

Wharton et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. N Engl J Med. 2025.

The compounds

More studies on Semaglutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking semaglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo